Maximum quantity allowed is 999
Please select the quantity
CAS RN: 85416-73-5 | Product Number: R0183
(S)-(+)-Rolipram
×
![]()
×
Purity: >98.0%(HPLC)
Synonyms:
- (S)-(+)-4-[3-(Cyclopentyloxy)-4-methoxyphenyl]pyrrolidin-2-one
Product Documents:
| Size | Unit Price | Same Day | 2-3 Business Days |
|---|---|---|---|
| 10MG |
$119.00
|
20 | 8 |
| 50MG |
$399.00
|
17 | 2 |
* Please contact our distributors or
TCI
to order our products. The above prices do not include freight cost, customs, and other charges to the destination.
* The storage conditions are subject to change without notice.
| Product Number | R0183 |
| Purity / Analysis Method | >98.0%(HPLC) |
| Molecular Formula / Molecular Weight | C__1__6H__2__1NO__3 = 275.35 |
| Physical State (20 deg.C) | Solid |
| Storage Temperature | Frozen (<0°C) |
| Condition to Avoid | Heat Sensitive |
| CAS RN | 85416-73-5 |
| Reaxys Registry Number | 6687797 |
| PubChem Substance ID | 354333407 |
| MDL Number | MFCD03093861 |
Specifications
| Appearance | White to Almost white powder to crystal |
| Purity(HPLC) | min. 98.0 area% |
| Optical purity(LC) | min. 97.0 ee% |
| Elemental analysis(Nitrogen) | 4.50 to 5.50 % |
| Melting point | 132.0 to 136.0 °C |
| Specific rotation [a]20/D | +29.0 to +34.0 deg(C=0.5, MeOH) |
| NMR | confirm to structure |
Properties (reference)
| Melting Point | 134 °C |
| Specific Rotation | 32° (C=0.5,MeOH) |
GHS
Related Laws:
Transport Information:
| H.S.code* | 2933.79-000 |
Application
(S)-(+)-Rolipram: The Less Active Enantiomer of Rolipram, PDE4 Inhibitor
(S)-(+)-Rolipram is the less active enantiomer of the PDE4 inhibitor rolipram [R0110]. The active enantiomer (R)-(-)-rolipram [R0182] also available. It has been reported that (S)-(-)-rolipram is approximately 3 times less potent than (R)-(+)-rolipram against PDE4. In 2015, Kobayashi et al. have been reported a new multistep continuous-flow synthesis of (R)- and (S)-rolipram using only columns packed with heterogeneous catalysts. (The product is for research purpose only.)
References
- Stereospecificity of rolipram actions on eosinophil cyclic AMP-specific phosphodiesterase
- Emesis induced by inhibitors of type IV cyclic nucleotide phosphodiesterase (PDE IV) in the ferret
- Multistep continuous-flow synthesis of (R)- and (S)-rolipram using heterogeneous catalysts
- Flow “Fine” Synthesis: High Yielding and Selective Organic Synthesis by Flow Methods
PubMed Literature
Articles/Brochures
Product Documents (Note: Some products will not have analytical charts available.)
Safety Data Sheet (SDS)
Please select Language.
The requested SDS is not available.
Please Contact Us for more information.
Specifications
C of A & Other Certificates
Please enter Lot Number
Incorrect Lot Number. Please input only the 4-5 alphanumeric characters before the hyphen.
Sample C of A
This is a sample C of A and may not represent a recently manufactured lot of the product.
A sample C of A for this product is not available at this time.
Analytical Charts
Please enter Lot Number
Incorrect Lot Number. Please input only the 4-5 alphanumeric characters before the hyphen.
The requested analytical chart is not available. Sorry for the inconvenience.